Hepatitis E virus: new faces of an old infection
Journal Title: Annals of Hepatology - Year 2013, Vol 12, Issue 6
Abstract
Hepatitis E virus is one of the most common causes of acute hepatitis worldwide, with the majority of cases occurring in Asia. In recent years, however, an increasing number of acute and chronic hepatitis E virus infections have been reported in industrialized countries. The importance of this infection resides in the associated morbidity and mortality. In acute cases, a high mortality rate has been reported in patients with previously undiagnosed alcoholic liver disease. Hepatitis E infection can become chronic in immunocompromised patients, such as solid organ transplant recipients, patients receiving chemotherapy, and HIV-infected patients, and lead to the development of hepatic fibrosis and cirrhosis. Hence, treatment strategies involving reductions in immunosuppressive regimens and therapy with ribavirin or peg-interferon have been evaluated. In terms of prevention, a promising new vaccine was recently licensed in China, although its efficacy is uncertain and potential adverse effects in risk groups such as chronic liver disease patients and pregnant women require investigation. In conclusion, physicians should be aware of hepatitis E as a cause of both acute and chronic hepatitis in immunocompromised patients. The best treatment option for HEV infection remains to be defined, but both ribavirin and peg-interferon may have a role in therapy for this condition.
Authors and Affiliations
Mar Riveiro-Barciela, Francisco Rodríguez-Frías, María Buti
Hepatology Highlights
Undifferentiated embryonal sarcoma of liver in an adult masquerading as complicated hydatid cyst
Benign or malignant hepatic lesions may rarely mimic inflammatory lesions on imaging. We describe a case of young adult male presenting with pain abdomen and fever of short duration. Imaging revealed large complex multis...
Clathrin heavy chain (CHC) staining for the diagnosis of small hepatocellular carcinoma
Abstract published under permission of Wiley-Blackwell
Glisson’s capsule blistering after hyperthermic intraperitoneal chemotherapy
Hypertermic intraperitoneal chemotherapy is a treatment option after cytorreduction of certain types of malignancies with peritoneal spread. Blistering of the Glisson’s capsule has not been previously reported as a conse...
Comments from the Editor-in-Chief on a New Section in the Journal
It is a pleasure to announce a new section in Annals of Hepatology, «Liver News Elsewhere». It has the main purpose to give readers a section for the discussion, comments and feedback about new articles published elsewhe...